MwanzoB9P0 • FRA
add
NovaBay Pharmaceuticals Inc
Bei iliyotangulia
€ 2.80
Bei za mwaka
€ 2.80 - € 2.80
Thamani ya kampuni katika soko
3.43M USD
Uwiano wa bei na mapato
-
Mgao wa faida
-
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 2.31M | 9.90% |
Matumizi ya uendeshaji wa biashara | 2.79M | 33.48% |
Mapato halisi | -1.21M | 70.50% |
Kiwango cha faida halisi | -52.49 | 73.16% |
Mapato kwa kila hisa | — | — |
EBITDA | -1.28M | -28.61% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | elfu 430.00 | -85.29% |
Jumla ya mali | 3.42M | -62.11% |
Jumla ya dhima | 3.55M | -37.90% |
Jumla ya hisa | elfu -129.00 | — |
hisa zilizosalia | 5.82M | — |
Uwiano wa bei na thamani | -93.33 | — |
Faida inayotokana na mali | -88.29% | — |
Faida inayotokana mtaji | -166.24% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -1.21M | 70.50% |
Pesa kutokana na shughuli | elfu -972.00 | -19.12% |
Pesa kutokana na uwekezaji | 0.00 | 100.00% |
Pesa kutokana na ufadhili | elfu 500.00 | 2,023.08% |
Mabadiliko halisi ya pesa taslimu | elfu -346.00 | -35.69% |
Mtiririko huru wa pesa | elfu -382.25 | -249.46% |
Kuhusu
NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on developing novel, fast-acting, synthetic anti-infectives compounds. These compounds are designed to mimic the body's defense system against infection. The company is currently focused on products for the eye care market. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis.
and NeutroPhase, used in treatment of Necrotizing Fasciitis Wikipedia
Ilianzishwa
2000
Makao Makuu
Tovuti
Wafanyakazi
14
